Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer lung cancer drug fails in two large studies

[Reuters - UK Focus] – Pfizer Inc on Monday said one of its experimental drugs had failed to meet its goals in two late-stage studies among patients who had received prior treatment for . . . → Read More: Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer lung cancer drug fails in two large studies Similar Articles: Amgen Inc. (NASDAQ:AMGN) – Amgen cholesterol drug succeeds in late-stage trial Company Update: Amgen Inc. (NASDAQ:AMGN) – Ahead of the Bell: Amgen’s cholesterol drug Company Update: Johnson & Johnson (NYSE:JNJ) – AstraZeneca to co-promote J&J prostate cancer drug in Japan